{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:30Z","timestamp":1786654050735,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0549200"],"award-info":[{"award-number":["2025ZD0549200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["735-63263231"],"award-info":[{"award-number":["735-63263231"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["735-92621010"],"award-info":[{"award-number":["735-92621010"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118204","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:05:00Z","timestamp":1782572700000},"page":"118204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IL-11 neutralizing antibodies alleviate pulmonary fibrosis in aging mice by inhibiting TGF-\u03b2\/NOX4\/IL-11 signaling pathway"],"prefix":"10.1016","volume":"252","author":[{"given":"Yang","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-xin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-guo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-3422","authenticated-orcid":false,"given":"Hong-gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-he","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.bcp.2026.118204_b0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic Pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118204_b0010","article-title":"Idiopathic Pulmonary Fibrosis: an Update on Pathogenesis","volume":"12","author":"Mei","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.bcp.2026.118204_b0015","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"146","key":"10.1016\/j.bcp.2026.118204_b0020","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2026.118204_b0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjms.2019.02.008","article-title":"The Aging Lung and Idiopathic Pulmonary Fibrosis","volume":"357","author":"Gulati","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bcp.2026.118204_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110836","article-title":"Cell senescence and fibrotic lung diseases","volume":"132","author":"Liu","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12931-021-01711-1","article-title":"Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management","volume":"22","author":"Luppi","year":"2021","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118204_b0040","doi-asserted-by":"crossref","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","article-title":"IPF lung fibroblasts have a senescent phenotype","volume":"313","author":"\u00c1lvarez","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118204_b0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.21037\/jtd.2019.02.11","article-title":"Cellular senescence and senescence-associated secretory phenotype: comparison of idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, and chronic obstructive pulmonary disease","volume":"11","author":"Okuda","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.bcp.2026.118204_b0050","article-title":"Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance","volume":"6(231):231ra247","author":"Hecker","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118204_b0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2017.02.216","article-title":"Inhibition of Bcl-2\/xl with ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in mice","volume":"99","author":"Pan","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bcp.2026.118204_b0060","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2026.118204_b0065","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02367-2016","article-title":"Senolytic drugs targetalveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo","volume":"50","author":"Lehmann","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.bcp.2026.118204_b0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2021.01.007","article-title":"Therapeutic Targeting of IL-11 for Chronic Lung Disease","volume":"42","author":"Kortekaas","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"7683","key":"10.1016\/j.bcp.2026.118204_b0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2026.118204_b0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"issue":"511","key":"10.1016\/j.bcp.2026.118204_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1237","article-title":"Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis","volume":"11","author":"Ng","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118204_b0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/imt.15.17","article-title":"IL-11 signaling as a therapeutic target for cancer","volume":"7","author":"Putoczki","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1465-9921-14-80","article-title":"Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease","volume":"14","author":"Lindahl","year":"2013","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118204_b0100","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s12276-019-0371-7","article-title":"TGF-\u03b21\/IL-11\/MEK\/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency","volume":"52","author":"Chen","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118204_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059348","article-title":"Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for \u201cactive\u201d disease","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2026.118204_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2613.2002.00220.x","article-title":"Time course of bleomycin-induced lung fibrosis","volume":"83","author":"Izbicki","year":"2002","journal-title":"Int. J. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0120","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF\u2011\u03b21: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)","volume":"48","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"9779","key":"10.1016\/j.bcp.2026.118204_b0125","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.bcp.2026.118204_b0130","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118204_b0135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V81.1.27.27","article-title":"Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets","volume":"81","author":"Du","year":"1993","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcp.2026.118204_b0145","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V89.11.3897","article-title":"Interleukin-11: review of molecular, cell biology, and clinical use","volume":"89","author":"Du","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2026.118204_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically","volume":"24","author":"Putoczki","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gutjnl-2021-326076","article-title":"Interleukin-11 drives human and mouse alcohol-related liver disease","volume":"72","author":"Effenberger","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2026.118204_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrcardio.2017.197","article-title":"Cardioprotection: IL-11 is a potential therapeutic target in cardiovascular fibrosis","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2026.118204_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bcp.2026.118204_b0170","article-title":"Stainier DYR et al: Interleukin-11 signaling promotes cellular reprogramming and limits fibrotic scarring during tissue regeneration","volume":"7(37):eabg6497","author":"Allanki","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.118204_b0175","volume":"18(12):904","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.118204_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112182","article-title":"IL-11 exacerbates cisplatin-induced acute kidney injury by facilitating apoptosis in renal tubular epithelial cells via ERK1\/2-Drp1\/TFEB-mediated defective autophagy","volume":"136","author":"Tao","year":"2025","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2026.118204_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14360","article-title":"Pro-inflammatory cytokine 11 plays a pivotal role in inflammaging-associated pathologies","volume":"23","author":"Izquierdo","year":"2024","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.bcp.2026.118204_b0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","article-title":"Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis","volume":"203","author":"Yao","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118204_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.202109-2151OC","article-title":"CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging","volume":"206","author":"Cui","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 5","key":"10.1016\/j.bcp.2026.118204_b0200","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1513\/AnnalsATS.201605-341AW","article-title":"Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis","volume":"13","author":"Pardo","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.bcp.2026.118204_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109511","article-title":"Reduced protein intake and aging affects the sustainment of hematopoiesis by impairing bone marrow mesenchymal stem cells","volume":"124","author":"Gon\u00e7alves","year":"2024","journal-title":"J. Nutr. Biochem."},{"issue":"20","key":"10.1016\/j.bcp.2026.118204_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012090","article-title":"Oxygen-Glucose Deprivation Promoted Fibroblast Senescence and Collagen Expression via IL11","volume":"23","author":"Song","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118204_b0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","article-title":"Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs","volume":"29","author":"Moodley","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118204_b0220","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13680","article-title":"Sirt1 overexpression improves senescence-associated pulmonary fibrosis induced by vitamin D deficiency through downregulating IL-11 transcription","volume":"21","author":"Zhou","year":"2022","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.118204_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030222","article-title":"Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis","volume":"14","author":"Torres-Machorro","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2026.118204_b0230","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thx.2009.113456","article-title":"NOX4\/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts","volume":"65","author":"Amara","year":"2010","journal-title":"Thorax"},{"issue":"14","key":"10.1016\/j.bcp.2026.118204_b0235","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1089\/ars.2019.7742","article-title":"Redox Imbalance in Idiopathic Pulmonary Fibrosis: a Role for Oxidant Cross-talk between NADPH Oxidase Enzymes and Mitochondria","volume":"31","author":"Veith","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.118204_b0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2017.07.023","article-title":"Lysocardiolipin acyltransferase regulates TGF-\u03b2 mediated lung fibroblast differentiation","volume":"112","author":"Huang","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118204_b0245","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.15252\/embr.201540750","article-title":"miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2","volume":"16","author":"Fierro-Fern\u00e1ndez","year":"2015","journal-title":"EMBO Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:16:53Z","timestamp":1786652213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0006295226005435"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118204","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-11 neutralizing antibodies alleviate pulmonary fibrosis in aging mice by inhibiting TGF-\u03b2\/NOX4\/IL-11 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118204"}}